Evaluation Model Used: gpt-5-mini
Number of Prompts Printed: 5
Number of Prompts Used for Calculating the Average for Each Metric: 20
QLoRA Adapter Configuration:
	Epoch: 2.0
	Rank: 16
	QLoRA Alpha: 16.0 

================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Undernutrition in neonates increases the risk of serious morbidities. The objective of this study was to describe neonatal morbidity associated with low body fat percentage (BF%) and measure the number of undernourished neonates defined by BF% and compare this with birth weight percentiles (<10th). Eligibility included term (≥37 wk) neonates. BF% measurements were undertaken by air displacement plethysmography. Data on neonatal outcomes were extracted from medical records and used to develop a measure of neonatal morbidity. We assessed the association between neonatal morbidity and population-based birth weight percentiles compared with the BF% measurements. Five hundred and eighty-one neonates were included. Low BF% was defined by 1 SD below the mean and identified in 73 per 1,000 live births. Neonatal morbidity was found in 3.4% of neonates. Birth weight percentile was associated with neonatal morbidity (odds ratio (OR): 1.03 (95% confidence interval (CI): 1.01, 1.05); P =<0.001). BF% was associated with a higher risk of neonatal morbidity (OR: 1.30 (95% CI: 1.15, 1.47); P =<0.001).
Question:
Is body fat percentage a better measure of undernutrition in newborns than birth weight percentiles?
[/INST]

Generated Answer: Low BF% is an important predictor of neonatal morbidity and should be considered when assessing neonatal nutritional status. It is recommended that all neonates have a BF% measurement as part of their routine care. In addition to birth weight, BF% may become a useful tool for identifying infants at risk of adverse health outcomes. This study highlights the need for a more detailed analysis of the relationship between birth weight and other indices of neonatal nutritional status. Future studies should investigate whether BF% measurements can help identify those infants who will benefit most from additional nutritional support. Further work should also explore how these findings might be incorporated into clinical practice. This study demonstrates the importance of measuring BF% in neonates. The use of BF% in combination with birth weight could provide an accurate measure of nutritional status and improve identification of infants at risk of adverse health outcomes. This has implications for future clinical trials and policy decisions relating to neonatal nutrition. Such a strategy would ensure that interventions are targeted appropriately, improving health outcomes for infants born preterm or small for gestational age. The use of BF% measurement in clinical practice would facilitate the development of standardized guidelines for neonatal nutrition, providing a uniform approach to the management of neonatal nutritional deficits. Standardization of this nature would facilitate comparison of results across different countries and regions.
2016 The Author(s). Published by Elsevier Ltd. All rights reserved.

Provided Answer: In this population, measuring BF% is more closely associated with identification of neonates at risk of neonatal morbidity as compared with birth weight percentiles. BF% measurements could assist with identifying neonates who are appropriately grown yet undernourished and exclude small neonates not at risk. 

correctness: 0.4
Reasoning:
The assistant correctly conveys the study's main conclusion that low BF% is an important predictor of neonatal morbidity and could help identify at-risk infants that birth weight percentiles miss. However, the reply overstates the evidence (recommending routine BF% measurement for all neonates) and incorrectly generalizes to preterm infants even though the study included only term neonates. It also fails to cite the comparative results (odds ratios, prevalence of low BF%) or discuss limitations that would temper implementation recommendations. These shortcomings make the response partially accurate but overly prescriptive.

conciseness: 0.3
Reasoning:
The assistant's reply is verbose and repetitive and does not concisely answer the question. It makes broad clinical recommendations (routine BF% measurement) without directly stating the study's main comparative finding — that BF% is more closely associated with neonatal morbidity than birth weight percentiles — and repeats speculative future directions rather than giving a succinct conclusion. 

relevance: 0.3
Reasoning:
The assistant's reply is only partly relevant. It correctly conveys the study's general conclusion that low BF% is an important predictor and may be more useful than birth weight percentiles for identifying neonates at risk. However, it does not cite or quote any specific text or data from the provided context (for example the reported odds ratios or the statement that BF% identified 73 per 1,000 and was more closely associated with morbidity). It also overstates the evidence by recommending routine universal BF% measurement and by mentioning preterm infants despite the study including only term neonates. These inaccuracies and unsupported recommendations reduce the response's fidelity to the context.

coherence: 0.5
Reasoning:
The response is generally coherent and organized: it summarizes the study's main implication (that low BF% predicts neonatal morbidity), outlines clinical and research implications, and suggests combining BF% with birth weight. However it is somewhat repetitive, does not directly answer the comparative question with a clear, concise conclusion (it hedges rather than stating whether BF% is superior), and overreaches by recommending routine BF% measurement and discussing preterm infants despite the study being limited to term neonates. It also includes an irrelevant publication line. Overall clarity is acceptable but the answer could be more focused and accurate to the study context.

helpfulness: 0.5
Reasoning:
The assistant's reply correctly emphasizes that low BF% is an important predictor of neonatal morbidity and that BF% can add value beyond birth weight percentiles. It also usefully suggests combining BF% with birth weight and calls for further research. However, the response overreaches by recommending routine BF% measurement for all neonates based on a single observational study, omits the study's specific comparative effect sizes, and inaccurately generalizes to preterm infants when the study included only term neonates. The answer is also repetitive and lacks discussion of limitations (sample size, feasibility, cost, or whether BF% improves classification sufficiently to change care). Overall, it is partially helpful but clinically overconfident and incomplete.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
We retrospectively collected and analyzed data of all diabetic patients affected by Charcot neuroarthropathy in combination with critical limb ischemia, which arrived to our care for the presence of foot lesions and underwent endovascular revascularization, followed by surgical and orthopedic treatment between January 2010 and January 2012. The primary end point was to assess the limb salvage rate. The secondary end point was to evaluate the healing time of the lesions. Ten diabetic patients (10 men; mean age 69.1±8.5 years), affected by ischemic Charcot neuroarthropathy underwent endovascular revascularization, surgical debridement and orthopedic correction. The limb salvage rate was 90%, avoiding major amputation in 9 patients. In one patient (10%) the infection could not be controlled and below-the-knee amputation was carried out. The required time to heal the lesion was in mean 197.4±22.4 days, after revascularization, surgical and orthopedic treatment.
Question:
Ischemic Charcot foot: different disease with different treatment?
[/INST]

Generated Answer: The results of this study suggest that an aggressive multidisciplinary approach including endovascular revascularization, surgical debridement and orthopedic correction may be effective in the treatment of ischemic Charcot neuroarthropathy in combination with critical limb ischemia. Further studies should be performed to confirm these preliminary results. However, it is important to keep in mind that the treatment of this disease is still challenging and requires careful selection of the right patient population. Moreover, a close follow-up is necessary to monitor the progress of the disease and the outcome of the treatment. The long-term results are not yet available. These observations should be confirmed by further investigations. This will allow us to better understand the natural history of this disease and its potential complications, and to improve the treatment of ischemic Charcot neuroarthropathy in combination with critical limb ischemia. The authors would like to thank Dr. Fabrizio Tiso for his contribution in collecting the data. The authors declare no conflict of interest. The manuscript has been read and approved by all the authors and they agree on the final version. The authors have nothing to disclose regarding funding or financial relationships related to this article. The work of Dr. P.M. G. Bizzotto was supported by Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. The work of Dr. S. M. D. Zucchelli was supported by Fondo per la ricerca clinica e biomedica (FRCB) grant number 38929. The work of Dr. R. C. Rossi was supported by Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. The work of Dr. P. Tiso was supported by Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. The work of Dr. A. P. Vitali was supported by Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. The work of Dr. A. L. M. L. Bonfiglioli was supported by Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. The work of Dr. R. C. Rossi was supported by Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Keywords: Charcot neuroarthropathy; critical limb ischemia; endovascular revascularization; orthopedic treatment; surgical debridement.

Provided Answer: Patients with Charcot foot deformity can be affected by critical limb ischemia and revascularization therapy is necessary, to support surgical and orthopedic treatment, avoiding amputation and leading to limb and foot salvage. 

correctness: 0.6
Reasoning:
The response is generally correct in emphasizing that ischemic Charcot neuroarthropathy benefits from a multidisciplinary approach that includes endovascular revascularization alongside surgical and orthopedic care, and it appropriately cautions that evidence is limited and longer follow‑up is needed. However, it is too cautious relative to the presented data (it does not state the reported 90% limb salvage and mean healing time ~197 days), does not directly answer whether ischemic Charcot is a distinct entity requiring different treatment, and includes irrelevant author/funding boilerplate. Overall it conveys the right clinical message but is incomplete and somewhat unfocused.

conciseness: 0.2
Reasoning:
The response is not concise: it is long, repetitive, and includes irrelevant funding/acknowledgment text, while failing to directly and succinctly answer whether ischemic Charcot foot is a distinct entity requiring different treatment. It describes a multidisciplinary approach but does not clearly compare ischemic versus non-ischemic Charcot or state a focused conclusion, so it is not to the point.

relevance: 0.5
Reasoning:
The response is partially relevant. It correctly highlights the need for a multidisciplinary approach including endovascular revascularization, surgical debridement, and orthopedic correction—points that appear in the context—but it does not directly answer whether ischemic Charcot foot is a distinct disease requiring different treatment. It also omits the study's concrete outcomes (e.g., 90% limb salvage, mean healing time) and includes long, irrelevant acknowledgments. Overall it addresses treatment in general but is incomplete and contains extraneous material.

coherence: 0.6
Reasoning:
The response is partially coherent: it concisely conveys that ischemic Charcot neuroarthropathy may require an aggressive, multidisciplinary approach that includes endovascular revascularization in addition to surgical and orthopedic care, and it appropriately cautions that results are preliminary and require further study. However, it does not directly answer the user’s phrasing (“different disease with different treatment?”) with a clear yes/no or comparative statement, and it includes irrelevant manuscript acknowledgments/funding text that detracts from clarity and focus. Overall the structure is readable but somewhat repetitive and contains extraneous material.

helpfulness: 0.6
Reasoning:
The assistant's reply is partly helpful: it correctly emphasizes that ischemic Charcot neuroarthropathy benefits from a multidisciplinary approach including endovascular revascularization alongside surgical and orthopedic care, and cautions about patient selection, close follow-up, and limited long‑term data — points consistent with the ground truth. However, the response is indirect to the question ("Ischemic Charcot foot: different disease with different treatment?"), is repetitive, and includes irrelevant manuscript acknowledgments/funding text. It does not clearly state that ischemic Charcot is not a wholly different disease but a Charcot foot complicated by critical limb ischemia that requires revascularization to enable limb‑salvage treatments.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Radical hysterectomy is recommended for endometrial adenocarcinoma patients with suspected gross cervical involvement. However, the efficacy of operative procedure has not been confirmed. The patients with endometrial adenocarcinoma who had suspected gross cervical involvement and underwent hysterectomy between 1995 and 2009 at seven institutions were retrospectively analysed (Gynecologic Oncology Trial and Investigation Consortium of North Kanto: GOTIC-005). Primary endpoint was overall survival, and secondary endpoints were progression-free survival and adverse effects. A total of 300 patients who underwent primary surgery were identified: 74 cases with radical hysterectomy (RH), 112 patients with modified radical hysterectomy (mRH), and 114 cases with simple hysterectomy (SH). Median age was 47 years, and median duration of follow-up was 47 months. There were no significant differences of age, performance status, body mass index, stage distribution, and adjuvant therapy among three groups. Multi-regression analysis revealed that age, grade, peritoneal cytology status, and lymph node involvement were identified as prognostic factors for OS; however, type of hysterectomy was not selected as independent prognostic factor for local recurrence-free survival, PFS, and OS. Additionally, patients treated with RH had longer operative time, higher rates of blood transfusion and severe urinary tract dysfunction.
Question:
Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?
[/INST]

Generated Answer: In this multi-institutional study, RH did not improve survival outcomes in endometrial cancer patients with suspected cervical involvement compared to mRH or SH. However, RH may be associated with an increased risk of severe complications. Further studies are required to establish optimal treatment strategies for such patients. To confirm these findings, we will conduct further prospective randomized controlled trials. Furthermore, we will investigate the role of vaginal cuff lymphadenectomy in endometrial cancer patients with cervical involvement. We also aim to develop a novel pathological classification system for endometrial cancer to provide more accurate information about prognosis. Finally, we will evaluate whether a new diagnostic method based on intraoperative frozen section examination could predict the need for RH. Therefore, our study provides important insights into the optimal management of endometrial cancer patients with cervical involvement and may have practical implications for clinicians. In conclusion, our results indicate that RH does not necessarily improve survival outcomes in endometrial cancer patients with suspected cervical involvement and may increase the risk of morbidity. In addition, it would be beneficial to identify patients with endometrial cancer who require RH. Our study highlights the importance of considering the benefits and risks of RH in individual patients. It is essential to identify patients who benefit from RH and those who do not. This approach should help to optimize treatment strategies and reduce morbidity. However, more research is necessary to determine which patients with endometrial cancer with suspected cervical involvement require RH. Further studies are warranted to address this issue. Future prospective studies are required to validate the present results. These studies should focus on identifying the patients who benefit from RH and developing a new classification system for endometrial cancer. As well as optimizing treatment strategies, this approach will help to improve patient quality of life and reduce healthcare costs. Thus, it is critical to define the appropriate indications for RH in endometrial cancer patients with cervical involvement. In conclusion, the current study shows that RH does not improve survival outcomes in endometrial cancer patients with suspected cervical involvement. Patients who undergo RH may suffer from more severe postoperative complications than patients who receive mRH or SH. However, further studies are required to confirm our results. Nevertheless, our findings suggest that RH is unnecessary in endometrial cancer patients with suspected cervical involvement. It is important to continue investigating the role of RH in endometrial cancer patients with suspected cervical involvement. As well as improving treatment outcomes, this approach may help to reduce healthcare costs and improve patient quality of life.
Author(s): M Kusunoki, S Ono, T Takahashi, T Hirao, Y Shimura, N Kinoshita, M Aihara, J Hirose, T Sugino, M Ito, H Ohashi, T Taguchi, T Fukayama, T Tanaka, K Fujii, Y Saito, T Matsumoto, T Matsuoka, T Tsunoda, K Sugawara, Y Nakamura

Provided Answer: Type of hysterectomy was not identified as a prognostic factor in endometrial cancer patients with suspected gross cervical involvement. Perioperative and late adverse events were more frequent in patients treated with RH. The present study could not find any survival benefit from RH for endometrial cancer patients with suspected gross cervical involvement. Surgical treatment in these patients should be further evaluated in prospective clinical studies. 

correctness: 0.6
Reasoning:
The assistant's answer correctly summarizes the study's main findings: radical hysterectomy (RH) did not improve survival compared with modified or simple hysterectomy and was associated with greater perioperative and late morbidity. However, the reply adds speculative and unsupported claims (e.g., "we will conduct further prospective randomized controlled trials," investigations of vaginal cuff lymphadenectomy, development of a novel pathological classification, and use of intraoperative frozen section) that are not reported in the ground truth and overstate conclusions by asserting RH is "unnecessary" rather than that no survival benefit was found and that further prospective evaluation is warranted. The response is also repetitive. Overall it is partly accurate but includes unwarranted extrapolations and stronger conclusions than the data justify.

conciseness: 0.3
Reasoning:
The response correctly states the main findings (no survival benefit from radical hysterectomy and increased complications) but is overly long and highly repetitive, with many unnecessary proposals for future research and repeated restatements of the same conclusions. It therefore fails the conciseness criterion despite answering the question.

relevance: 0.4
Reasoning:
The assistant's reply correctly summarizes the study's main conclusions (radical hysterectomy did not improve survival and was associated with more complications), so it is relevant to the question. However, it does not include or cite any direct quote from the provided context, and it adds numerous speculative future plans and repetitive statements that are not supported by the quoted study text. Overall the answer is relevant but lacks reference to an actual quote from the context and includes extraneous content.

coherence: 0.6
Reasoning:
The assistant's reply communicates the main finding (that radical hysterectomy did not improve survival and was associated with greater morbidity) in a clear, direct way, so the core answer is coherent. However, the text is poorly organized and overly repetitive, with multiple near-duplicate concluding statements. It also introduces speculative future plans and first‑person phrasing ("we will...") that are not necessary for answering the question and reduce concision and focus. Overall, it answers coherently but with significant redundancy and weakened structure.

helpfulness: 0.6
Reasoning:
Explanation: The assistant's answer correctly summarizes the study's main findings — radical hysterectomy (RH) did not improve survival compared with modified or simple hysterectomy and was associated with greater perioperative and late morbidity — which directly answers the question. However, the reply is overly long and repetitive, contains speculative/unnecessary statements about conducting future trials and new procedures presented as if the authors (or assistant) will carry them out, and adds proposed research directions that were not requested. These issues reduce clarity and introduce inappropriate assertions beyond the study results.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
The morbidity and mortality of pancreaticoduodenectomy (PD) have significantly decreased over the past decades to the point that they are no longer the sole indicators of quality and safety. In recent times, hospital readmission is increasingly used as a quality metric for surgical performance and has direct implications on health-care costs. We sought to delineate the natural history and predictive factors of readmissions after PD. The clinicopathologic and long-term follow-up data of 1,173 consecutive patients who underwent PD between August 2002 and August 2012 at the Massachusetts General Hospital were reviewed. The NSQIP database was linked with our clinical database to supplement perioperative data. Readmissions unrelated to the index admission were omitted. We identified 173 (15 %) patients who required readmission after PD within the study period. The readmission rate was higher in the second half of the decade when compared to the first half (18.6 vs 12.3 %, p = 0.003), despite a stable 7-day median length of stay. Readmitted patients were analyzed against those without readmissions after PD. The demographics and tumor pathology of both groups did not differ significantly. In the multivariate logistic regression analysis, pancreatic fistula (18.5 vs 11.3 %, OR 1.86, p = 0.004), multivisceral resection at time of PD (3.5 vs 0.6 %, OR 4.02, p = 0.02), length of initial hospital stay>7 days (59.5 vs 42.5 %, OR 1.57, p = 0.01), and ICU admissions (11.6 vs 3.4 %, OR 2.90, p = 0.0005) were independently associated with readmissions. There were no postoperative biochemical variables that were predictive of readmissions. Fifty percent (n = 87) of the readmissions occurred within 7 days from initial operative discharge. The reasons for immediate (≤7 days) and nonimmediate (>7 days) readmissions differed; ileus, delayed gastric emptying, and pneumonia were more common in early readmissions, whereas wound infection, failure to thrive, and intra-abdominal hemorrhage were associated with late readmissions. The incidences of readmissions due to pancreatic fistulas and intra-abdominal abscesses were equally distributed between both time frames. The frequency of readmission after PD is 15 % and has been on the uptrend over the last decade.
Question:
Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?
[/INST]

Generated Answer: This study highlights the need for continued efforts to reduce the incidence of readmissions after PD by optimizing perioperative care, particularly in patients with prolonged hospital stays. We also demonstrate that readmissions occur in different time frames and may be attributable to different causes. Thus, prevention strategies should be tailored according to the timing of readmissions. The use of preoperative risk stratification tools may help identify high-risk patients who require close monitoring during their initial hospital stay and subsequent outpatient follow-up. Moreover, the development of standardized guidelines for postoperative care and management could improve patient outcomes and reduce readmissions. Finally, the incorporation of readmission rates into hospital and insurance company metrics would encourage hospitals and surgeons to prioritize this important aspect of quality and safety. Future studies will focus on developing a comprehensive algorithm for identifying patients at high risk for readmissions. This algorithm would include preoperative risk scores, clinical and laboratory parameters, and operative techniques that could predict future complications. These findings would allow us to develop targeted interventions aimed at reducing readmissions and improving patient outcomes. In conclusion, readmissions after PD are common and may be preventable with optimal perioperative care and close monitoring. Further investigations are needed to identify the most effective strategies to prevent these readmissions and improve patient outcomes. The use of readmission rates as a metric for measuring quality and safety will drive the development of evidence-based practices to optimize care and reduce health-care costs.

Provided Answer: The complexity of initial resection and pancreatic fistula were independently associated with hospital readmissions after PD. Further efforts should be centered on preventing early readmissions, which constitute half of all readmissions. 

correctness: 0.6
Reasoning:
The assistant's reply is generally sensible—it correctly notes that readmissions after PD are common, occur in distinct early and late time frames, and that tailored perioperative care, risk stratification, and closer monitoring could reduce readmissions. However, it omits the study's key, specific findings: that pancreatic fistula and the complexity of the initial resection (multivisceral resection) were independent predictors of readmission, and that half of readmissions occur within 7 days (supporting a particular emphasis on preventing early readmissions). The recommendations are mostly generic and do not reference those specific actionable risk factors identified by the study.

conciseness: 0.3
Reasoning:
The response is wordy and repetitive and therefore not concise. It offers general prevention ideas (risk stratification, tailored follow-up, guidelines) but fails to highlight the study’s main, specific findings — that pancreatic fistula and complexity of resection (multivisceral resection) were independent predictors — and it does not emphasize that half of readmissions occur early (≤7 days) and thus prevention efforts should target early readmissions. Because it is long-winded and omits the key actionable points from the ground truth, it scores low on conciseness and relevance.

relevance: 0.6
Reasoning:
The assistant's reply is broadly relevant: it outlines plausible prevention strategies (risk stratification, tailored perioperative care, monitoring, guidelines) and notes that readmissions occur in different time frames. However it fails to reference the study's key independent predictors (pancreatic fistula and complexity/multivisceral resection) and does not emphasize the important finding that half of readmissions occur within 7 days — a point the ground truth recommends prioritizing. Overall the answer is reasonable but incomplete and not tightly grounded in the specific reported findings.

coherence: 0.7
Reasoning:
The response is generally coherent and well-organized: it summarizes broad prevention strategies (perioperative optimization, tailored timing-based approaches, risk stratification, standardized care pathways, and future predictive algorithms) and emphasizes the need for further study. However, it omits two key, specific findings from the study that should guide prevention priorities: (1) pancreatic fistula and complexity of resection (multivisceral resection) were independent predictors of readmission, and (2) half of readmissions occur within 7 days, meaning prevention efforts should particularly target early readmissions. Including those specifics would make the answer more directly actionable and better aligned with the study results.

helpfulness: 0.5
Reasoning:
The assistant's reply is moderately helpful: it offers sensible, general strategies (risk stratification, tailored post-discharge follow-up, standardized postoperative care, and development of predictive algorithms) and notes that readmissions occur in different time frames. However, it omits key, study-specific findings and actionable priorities from the ground truth. Notably missing are (1) explicit identification of the independent predictors found in the study (pancreatic fistula and complexity of initial resection/multivisceral resection), (2) the important observation that 50% of readmissions occur within 7 days and therefore early readmission prevention should be a primary focus, and (3) the distinct causes of early versus late readmissions that would inform targeted prevention strategies. The recommendations are generic and somewhat speculative rather than tied closely to the study’s specific results.

================================================================================
Average correctness Score: 0.465
Average conciseness Score: 0.355
Average relevance Score: 0.465
Average coherence Score: 0.515
Average helpfulness Score: 0.47
